AOA vs. ABIM: Why limit osteopathic growth?

Growth of osteopathic medicine is exciting for internal medicine and other specialties. Why limit that now? American Osteopathic Association (AOA) President Robert G.G. Piccinini, D.O., D.FACN, continues his discussion about the AOA’s recent lawsuit against the American Board of Internal Medicine.

Medical Economics: When you mention some of the positions that osteopathic physicians have risen to, it's an impressive list, so that's really cool to think about. It's got to be exciting for the profession.

Robert G.G. Piccinini, D.O., D.FACN: It is, it really is, and they're great physicians and they're doing great work for their patients and their constituents, and that's the story we want to tell. And that's the story that we want to emphasize, that osteopathic positions, osteopathic-certified board-certified physicians are a crucial part of the health care landscape, and this policy being as unlawful as it is, is limiting that full goal of that whole aspect of what an osteopathic physician can do.